← Evidence map

ArticleTranslational lung cancer research2026

Assessment of tumor mutation burden based on whole-exome sequencing of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid in advanced non-small cell lung cancer treated with pembrolizumab: a prospective, multicenter, observational study.

Heejoung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Assessment of tumor mutation burden based on whole-exome sequencing of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid in advanced non-small cell lung cancer treated with pembrolizumab: a prospective, multicenter, observational study. | Socratic